Refine by
Cancerous Target Articles & Analysis
101 articles found
ENPP2 in Disease: Insights from Cancer, Fibrosis, and Neurobiology Pathological dysregulation of ENPP2 is associated with multiple diseases. ...
Adjuvant therapies may include radiation, chemotherapy, and targeted therapy. The choice of therapy typically hinges on the tumor’s receptor status and specific genetic mutations. For instance, hormone receptor-positive tumors may benefit from endocrine therapy, while HER2-positive cancers might be treated with targeted agents like ...
Whether it is medical research or drug manufacturing, tablet press is a vital link. Let's see how to choose the one that suits you best.Grand pack.The field of drug delivery is constantly evolving, driven by the core goal of improving therapeutic outcomes—enhancing efficacy, reducing toxicity, boosting patient compliance, and even enabling entirely new medical treatments. The global drug delivery ...
Antibody-drug conjugates (ADCs) combine potent small-molecule drugs with monoclonal antibodies for targeted cancer therapy. A major challenge is loading enough drug onto each antibody without compromising solubility or circulation time. ...
These specialized compounds often target cancer by interfering with cell division, signal transduction, or angiogenesis processes. Modern oncology APIs include targeted therapies like kinase inhibitors and monoclonal antibodies that precisely attack cancer cells while minimizing damage to healthy tissues. ...
Alfa Cytology has revealed new FAP-targeted therapeutics development services that aim to develop precise and effective cancer treatments. ...
Cancer treatment has witnessed transformative advancements over the past few decades, notably with the emergence of CAR-T (Chimeric Antigen Receptor T-cell) therapy. This revolutionary therapy harnesses the body's immune system by genetically engineering T-cells to target and destroy cancer cells. Among the pioneering companies at the forefront ...
This method is particularly useful in identifying genetic abnormalities associated with cancer, such as gene amplifications, deletions, and translocations, which can play a critical role in the diagnosis and treatment planning of cancer patients. ...
In recent years, the field of antibody drug design has become increasingly significant in the realm of therapeutic development, driven by the need for more effective and targeted treatments for various diseases, including cancer, autoimmune disorders, and infectious diseases. ...
The biological functions of platelets are preserved in platelet micromotors with their ability to target cancer cells and pathogens. Biofuels enable motor-shaped platelet micromotors to achieve directed propulsion. As platelets circulate in the blood the micromotors activate asymmetrical reactions to breakdown urea and ammonia while producing carbon dioxide which ...
The pioneering initiative represents a major advancement in targeting cancer treatments to destroy malignant cells effectively while reducing damage to healthy tissues. ...
In recent years, the fight against cancer has seen significant advances, particularly with the emergence of targeted therapy. ...
Antibody-Drug Conjugates (ADCs) represent a groundbreaking advancement in targeted cancer therapy, combining the specificity of antibodies with the potency of cytotoxic drugs. ...
This phenomenon offers a remarkable opportunity in cancer therapy. Tumors often exhibit mutations that can be exploited for targeted treatments. ...
Immuno-oncology is an innovative field that utilizes the body’s immune system to combat cancer. By harnessing the natural capabilities of the immune system, immuno-oncology services are revolutionizing the way we approach cancer treatment, offering novel therapies that are changing the prognosis for many patients. Understanding Immuno-Oncology ...
When mutated, Rb loses its ability to control division, often leading to cancer. Recent Research in Cell Cycle Regulation 1. Alternative Cell Cycle Pathways A recent study identified an alternative cell cycle mechanism in certain cancer cells, revealing how some tumors bypass traditional regulatory checkpoints. ...
Alfa Cytology has launched ovarian cancer therapy development services. Alfa Cytology, a prominent services provider in oncology, has launched its cutting-edge ovarian cancer therapy development services. ...
Alfa Cytology unveils advanced cancer immunotherapy development services. Alfa Cytology, a renowned services supplier in oncology, has recently introduced its groundbreaking cancer immunotherapy development services. ...
This article explores the profound impact of nanotechnology on drug delivery systems and its correlation with formulation development services Enhanced Drug Delivery and Targeting One of the most significant contributions of nanotechnology to pharmaceutical formulations is its ability to enhance drug delivery and targeting. Through the design and utilization of ...
This cutting-edge initiative represents a major advancement in creating more precise and versatile cancer treatment paradigms. As the landscape of cancer treatment continues to evolve, there is a growing need for innovative and personalized therapeutic approaches. Conventional therapies often fall short in their ability to selectively target ...